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ABSTRACT 
Background: Patellofemoral pain is a multifactorial and often persistent knee condition. 
One strategy to enhance patient outcomes is using clinically assessable patient 
characteristics to predict the outcome and match a specific treatment to an individual  
Aim: A systematic review was conducted to determine which baseline patient 
characteristics were i) associated with patient outcome (prognosis); or ii) modified patient 
outcome from a specific treatment (treatment effect modifiers).  
Methods: Six electronic databases were searched (July 2016) for studies evaluating the 
association between those with patellofemoral pain, their characteristics and outcome. All 
studies were appraised using the Epidemiological Appraisal Instrument. Studies that 
aimed to identify treatment effect modifiers underwent a checklist for methodological 
quality.  
Results: The 24 included studies evaluated 180 participant characteristics. Twelve 
studies investigated prognosis, and 12 studies investigated potential treatment effect 
modifiers. Important methodological limitations were identified. Some prognostic studies 
used a retrospective design. Studies aiming to identify treatment effect modifiers often 
analysed too many variables for the limiting sample size and typically failed to use a 
control or comparator treatment group. Sixteen factors were reported to be associated 
with a poor outcome, with longer duration of symptoms the most reported (>4months). 
Preliminary evidence suggests increased midfoot mobility may predict those who have a 
successful outcome to foot orthoses.  
Conclusion:  Current evidence can identify those with increased risk of a poor outcome, 
but methodological limitations make it difficult to predict the outcome after one specific 
treatment compared to another. Adequately designed randomised trials are needed to 
identify treatment effect modifiers.   
 
WORD COUNT: 250 
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1.0 INTRODUCTION 
Patellofemoral pain (PFP) is a prevalent and persistent knee condition [1 2] that affects 
approximately 1 in 20 teenagers and 1 in 10 adult women. [3-7] Despite receiving 
evidence-based treatments that are initially effective, more than one third of patients’ still 
report persistent symptoms 12 months later [2] with approximately 25% reporting 
symptoms up to 20 years later.[8] It might be helpful clinically to know whether certain 
prognostic factors can identify patients with PFP who are at risk for a poor outcome. A 
review identified a number of prognostic factors for outcomes in those with PFP (e.g., 
age, pain severity, foot posture/motion), [9]  only presented differences between groups 
at baseline, which are not helpful to the clinician wanting to determine the prognosis of a 
specific patient. 
 
The complex and multifactorial nature of PFP leads to a heterogeneous clinical 
presentation.[10] A recent best practice guide recommended that treatment be tailored to 
each patient’s presentation, but it did not provide direction for the clinician on how to 
individually tailor treatment.[11] Prognostic factors are patient characteristics that help to 
determine a specific outcome within a certain time period. [12 13] Treatment effect 
modifiers are patient characteristics that predict a successful outcome from a specific 
treatment. An evidence-based approach to individually tailor treatment requires the 
identification of treatment effect modifiers, because although prognostic factors help 
predict the likelihood of an outcome within a certain time period, they cannot predict the 
likelihood of an outcome after a specific treatment. [14]  
 
To inform clinical practice and research related to PFP, the purpose of this systematic 
review was to determine which baseline patient characteristics were: (i) associated with a 
poor outcome (prognostic factors); or (ii) associated with a successful outcome after a 
specific treatment (treatment effect modifiers).  
` 
2.0 METHODS 
2.1 Search Strategy 
The systematic review was conducted following the PRISMA guideline. [15] Electronic 
databases (Medline, Scopus, Embase, CINAHL, SPORTDiscus and Web of Science) 
were searched up to July 2016 for studies investigating conservative (non-surgical) 
treatments for PFP.  Key search terms relating to PFP and other such synonyms used in 
all databases were adapted from similar search strategies. [10 16 17] Keywords used to 
narrow the search to the aim of the review were success*, factor*, predict*, charact*, 
prognos*. Searches were limited to human studies with no language restrictions 
(appendix 1). The protocol for the systematic review was not registered.    
 
2.2 Eligibility 
Studies were included if they had investigated: (a) participants diagnosed with PFP 
determined by clinicians based on the report of retro or peripatellar pain that was 
provoked by either a partial squat, stair ascent or descent and pain reported during 
palpation of peri-articular structures, and (b) an association between patient 
characteristics that were measured at the outset of the study and the outcome (status of 
the condition) at a later time (minimum period of 1 week). Only conservative (non-
surgical) approaches were included. Studies were excluded if they included pain from 
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structures other than the patellofemoral joint, and other knee pathologies such as internal 
derangement, knee ligament insufficiency or patellar tendinopathy. Case reports or 
reviews of the literature were also excluded.  
 
2.3 Review process 
All identified studies were imported into Endnote X6 (Thomson Reuters, Carlsbad, 
California, USA) and duplicates removed. Two reviewers (MM & MSR) independently 
assessed study titles and abstracts for eligibility with a third reviewer (BV) available if 
necessary to resolve discrepancies. Where there was duplication or pooling of data from 
different trials, only the primary publication (the study of the highest relevancy to the 
purposes of this review as determined by all three reviewers) was included. Reference 
lists of all publications considered for inclusion were hand-searched recursively until no 
additional eligible publications were identified.  
 
2.4 Quality assessment 
Two reviewers (MM and MSR) independently assessed papers for quality. Any 
discrepancies were discussed to reach consensus, and if discrepancies remained, a third 
reviewer was consulted (BV). Study quality of all included studies was assessed using 
the Epidemiological Appraisal Instrument (EAI) [18] in a method used in previous reviews. 
[19 20] Items were scored as Yes (score = 2), Partial (score = 1), No (score = 0), Unable 
to determine (score = 0) of the applicable items. An average score was then calculated 
across all applicable items for each study (range 0-2). The EAI is a valid and reliable 
appraisal instrument for systematic reviews [21]  
 
Studies that aimed to investigate predictors of outcome after a specific treatment were 
further evaluated for quality using a checklist for prescriptive, derivation-based clinical 
prediction rules (QUADCPR). [22] The QUADCPR was designed and developed using a 
3-round Delphi process involving physicians, epidemiologists and physical therapists. It 
includes 23 items across 4 sections – (i) sample and participants (ii) outcome measure 
(iii) quality of tests and measures and (iv) statistical assumptions. Each item is scored 
yes, no, or unclear without generating a quantitative score. Two modifications were made 
to the QUADCPR for the purposes of this review. First, in accordance with the statement 
on Transparent Reporting of a multivariable prediction model for Individual Prognosis or 
Diagnosis (TRIPOD) [23], an adequately powered study required at least 10 participants 
in the limiting sample size (group with least frequent outcome) for each variable analyzed 
as a potential predictor (Question 18). Second, in discussion with the corresponding 
author of the QUADCPR, a fifth section was added to assess whether outcomes are 
treatment effect modifiers - (v) quality of treatment approach. This section addressed the 
quality of the treatment approach using published recommendations on the preferred 
study methods for identifying treatment effect modifiers and subgroup effects.[14 24 25] 
An additional 4 questions were inserted into the checklist (Questions 24 -27) that 
addressed treatment explanation and implementation of the target treatment and 
comparator treatment.  
 
2.5 Data Extraction and Analysis 
Study details were extracted by MM and checked by MSR. Details extracted were: 
publication details, sample characteristics, participant demographics, study methods 
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including study design, outcome measures, any intervention(s), and the baseline factors 
studied. Study results were extracted by following the definitions for a successful 
outcome or poor outcome applied by each individual study. Outcome measures used per 
study are detailed in Table 2 (col. 4) and Table 3 (col. 3). Relationships between baseline 
predictors and a poor outcome (i.e., prognosis) were expressed as R2, whereas baseline 
predictors and a successful outcome after a specific treatment were quantified by 
extracting positive likelihood ratios (LR+) and odds ratios (OR). Positive likelihood ratios 
indicate the probability of having a successful outcome if the identified predictor is 
present.  Shifts in probability of a successful outcome are categorized as small and rarely 
important (LR+ 1-2), small but sometimes important (LR+ 2-5), moderate shift (LR+ 5-10) 
or large and often conclusive (LR+ >10). [26] Odds ratios measure the association 
between the exposure and an outcome (OR >1 higher odds; OR <1 lower odds). For 
studies that did not report OR, LR+ or post-test probability scores, authors were 
contacted and those indices were calculated from available data. Meta-analyses were 
performed where appropriate. 
 
 
3. 0 RESULTS  
3.1 Search results and critical appraisal of methods 
The search retrieved 11629 citations, of which 7339 unique titles and abstracts were 
reviewed, with 59 papers identified for full text examination. Twenty-four studies met the 
eligibility criteria for quality assessment and data extraction, (figure 1) which evaluated 
180 participant characteristics (appendix 2). The most frequently evaluated 
characteristics were age and sex (n=14 studies), knee pain duration (n=13), Q angle, 
body mass index, weight and height (n=8), sports participation (n=6) and navicular drop 
(n=5 studies). Twelve studies investigated patient characteristics associated with a poor 
outcome, and the remaining 12 studies investigated patient characteristics associated 
with successful outcome after a specific treatment.  
 
 Figure 1 PRISMA flow diagram 
 
3.2 Quality assessment  
Overall across all 24 studies, there was good conformity of the study aims, treatments, 
assessments and main findings on the EAI checklist. Very few studies reported adequate 
adjustment for covariates in the statistical analyses, blinding of observers or reporting of 
adverse events. There was also a lack of reporting reliability and validity of the main 
outcome measures used (see online appendix 3). Twelve studies investigated prognostic 
factors for a poor outcome (three randomized controlled trials, eight case series and one 
had no treatment), only one of the randomized trials [27] adjusted for treatment and 
reported it was not a confounder.  
 
In addition to being evaluated for quality on the EAI, studies that investigated patient 
characteristics associated with successful outcome after a specific treatment were 
appraised under the QUADCPR checklist (n=12). Overall on the QUADCPR quality 
checklist, significant methodological limitations were identified with only one study using a 
control group. Only one study [28] had adequate statistical power with at least 10 
participants in the limiting sample size (group with least frequent outcome) for each 
	6	
Clinical	predictors	of	outcome	systematic	review	manuscript	20160222	
potential predictor included in the statistical analysis. Even if a lower threshold of 5 
participants in the limiting sample size for each potential predictor is used, [29] this was 
still the only study that had adequate statistical power. An issue with potential reporting 
bias was identified with only four [28 30-32] of the twelve studies administered outcome 
measures in a blinded fashion and in only three studies were the examining [28 30 33] or 
treating [30 32 34] clinicians blind to the outcome measures (table 1).  
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Table 1 Quality appraisal using a checklist for prescriptive, derivation-based clinical prediction rules (QUADCPR) 
Questions	 Barton	
2011a	
Barton	
2011b	
Crowell	
2012	
Huang	
2015	
Iverson	
2008	
Lan	
2010	
Lankhorst	
2015	
Mills	
2012	
Peng	
2015	
Rathleff	
2015	
Sutlive	
2004	
Vicenzino	
2010	
1.	Setting	and	location	reflective		 	 	 	 	 	 	 	 	 	 	 	 	
2.	Inclusion	and	exclusion	criteria	 	 	 	 	 	 	 	 	 	 	 	 	
3.	Sample	characteristics		 	 	 	 	 	 	 	 	 	 	 	 	
4.	Prospective	and	consecutive	sampling	 	 	 	 	 	 	 	 	 	 	 	 	
5.	Outcome	measure(s)	defined	 	 	 	 	 	 	 	 	 	 	 	 	
6.	Outcome	measure	reliability,	validity	and	
sensitivity	to	change	
	 	 	 	 	 	 	 	 	 	 	 	
7.	Blinded	outcome	measure(s)		 	 	 	 	 	 	 	 	 	 	 	 	
8.	Outcome	measure	defined	(positive/	negative)		 	 	 	 	 	 	 	 	 	 	 	 	
9.	Logical	rationale	for	predictor	test		 	 	 	 	 	 	 	 	 	 	 	 	
10.	Predictor	test	was	performed	pre-treatment	 	 	 	 	 	 	 	 	 	 	 	 	
11.	Predictor	test	and	measures	were	explained	in	
detail	
	 	 	 	 	 	 	 	 	 	 	 	
12.	Predictor	tests/	measures	performed	in	a	
clinically	consistent,	acceptable,	and	appropriate	
method	
	 	 	 	 	 	 	 	 	 	 	 	
13.	Examining	clinicians	blinded	to	the	outcome	
measures		
	 	 	 	 	 	 	 	 	 	 	 	
14.	Treating	clinicians	blinded	to	outcome	measures	 	 	 	 	 	 	 	 	 	 	 	 	
15.	Reliable	predictor	tests	and	measures	used	
(>0.60	Kappa	and	or	0.70	ICC)		
	 	 	 	 	 	 	 	 	 	 	 	
16.	Appropriate	time	intervals		 	 	 	 	 	 	 	 	 	 	 	 	
17.	Equivocal	or	indeterminable	results	were	
reported	
	 	 	 	 	 	 	 	 	 	 	 	
18.	Adequate	sample	powering	(10	subjects	in	the	
limiting	sample	size	for	each	potential	predictor	
variable)	*footnote	
	 	 	 	 	 	 	 	 	 	 	 	
19.	First	order	interactions	were	assessed	and	
reported	
	 	 	 	 	 	 	 	 	 	 	 	
20.	The	statistical	significance	of	the	model	or	"fit"	
was	reported	
	 	 	 	 	 	 	 	 	 	 	 	
21.	Confidence	intervals	of	the	regression	analyses	
reported		
	 	 	 	 	 	 	 	 	 	 	 	
22.	Irrelevant	predictors	removed	prior	to	
multivariate	modeling		
	 	 	 	 	 	 	 	 	 	 	 	
23.	Statistical	results	of	the	clinical	prediction	rule	
were	reported	using	95%	CI		
	 	 	 	 	 	 	 	 	 	 	 	
24.	Treatment/	intervention	procedures	are	
explained	in	detail	
	 	 	 	 	 	 	 	 	 	 	 	
25.	Treatment/	intervention(s)	were	performed	in	a	
clinically	consistent,	acceptable,	and	appropriate	
method	
	 	 	 	 	 	 	 	 	 	 	 	
26.	Comparator	treatment/	intervention	procedures	
are	explained	in	detail	
	 	 	 	 	 	 	 	 	 	 	 	
27.	Comparator	treatment/	intervention(s)	were	
performed	in	a	clinically	consistent,	acceptable,	and	
appropriate	method	
	 	 	 	 	 	 	 	 	 	 	 	
Black	shading	=	"Yes",	Grey	shading	=	"Unclear",	White	(no	shading)	=	"No"	
Inter-rater	agreement	between	the	quality	assessors	was	92%	across	all	13	papers.	
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*footnote:	Modified	in	accordance	with	the	TRIPOD	statement	[23]	recommendation	for	a	minimum	of	10	subjects	in	the	limiting	sample	size	(i.e.	those	who	
experienced	the	least	frequent	outcome)	for	each	potential	predictor	variable	included	in	the	analysis.		
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3.3 Patient characteristics associated with a poor outcome (prognosis)  
Sixteen patient-reported and anatomical characteristics were associated with a poor 
outcome, with degree of association (e.g., R2) ranging from 27 to 46% (table 2). The 
patient-reported characteristics were duration of PFP symptoms [27 35 36] bilateral 
symptoms, [37] higher frequency of pain occurrence, [38] older age, [39] female gender, 
[36] lower baseline Kujala knee pain score and function (Kujala scale and functional index 
questionnaire in [27]), poor health and low/middle education level. [37] 
 
Anatomical characteristics associated with a poor outcome were swelling of the knee 
(self-reported by the participant in [37]), patellar hypermobility, [36] slower vastus 
medialis obliquus reflex response, [35] larger side to side differences in isometric 
quadriceps muscle strength, [40] smaller quadriceps cross sectional area on MRI and 
lower eccentric knee strength, [38] evidence of chondromalacia patella on MRI and a 
tibial tubercle lateral deviation > 14.6 mm relative to the trochlear groove. [41]  
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Table 2 Patient characteristics associated with a poor outcome (prognosis) 
Author	 Sample	
size	(n)	
Variables	
assessed	
(n)	
Outcome	
measures	
Univariate	(p)	
or		
Multivariate	
(p)		
Follow	
up	
Prognostic	variables	for	a	poor	
outcome	
Explained	
Variance	(R2)	
Covariate	 Intervention(s)	 Trial	Type	
Blond	
and	
Hansen	
1998	[36]	
250	 12	 Pain	resolution	 Univariate	
(p<0.05)	
5.7	yrs	 	Hypermobile	patella	
>4month	duration	of	symptoms	
Female	
-	 None	
specified	
Advised	to	wear	knee	
brace	and	VMO	exercises:	
open	and	closed	kinetic	
chain	(Phase	1:	non-
loaded,	phase	2:	loaded	
exercises,	phase	3:	return	
to	main	athletic	activity)	
	
Retrospective	
case	study	
Collins	et	
al	2010	
[27]	
179		 11	 1.	Pain	(VAS)	
2.	Kujala	Scale		
3.	Functional	
Index	
Questionnaire	
	
Univariate	
(p<0.01)	then	
multivariate	
(p<0.01)	
6	wks	
	
1.	High	pain	severity		
2.	Longer	duration	of	symptoms,	
lower	baseline	Kujala	score	
3.Longer	duration	of	symptoms,	
lower	baseline	Functional	Index	
Questionnaire	score	
1.	R2	=	23%		
2.	R2	=	40.1%	
3.	R2	=	38.6%	
Treatment	
group	
Flat	inserts	-	versus	-	foot	
orthoses	–	versus	-	physio	
exercises	(patellar	
mobilization,	patellar	
taping,	VMO	retraining,	
Hip	ER	retaining	and	hip	
and	hamstring	stretches)	–	
versus	-	foot	orthoses	and	
physio	exercises	
	
Randomized	
Controlled	
Trial	
12	wks	
1.	Nil	
2.	Lower	baseline	Kujala	score	
3.	Lower	baseline	kujala	score	
1.	-	
2.	R2	=	28%	
3.	R2	=	22%	
52	wks	
1.Nil	
2.	Long	duration	of	symptoms,	
lower	baseline	Kujala	
3.	Long	duration	of	symptoms	
1.	-	
2.	R2	=	29.5%	
3.	R2	=	26.6%	
Kannus	
and	
Nittymaki	
1994	[39]	
49	 22	 1.	Pain	(VAS)	
2.	Lysholm	scale	
3.	Tegner	scale	
Univariate	
(p<0.05)	then	
multivariate	
(p<0.05)	
6	wks	
	
1.	Older	age	
2.	Older	age	
3.	Older	age		
-	 None	
specified	
Rest,	quadriceps	strength,		
quadriceps	stretch,	cold	
pack	(10mins)	non-
steroidal	anti-
inflammatory	medication	
and	intra-articular	
injections	(n=33,	5x	-	
1x/week)	of	physiologic	
saline	(n=17)	or	
glucosamine	(n=16)	
Prospective	
cohort	study	
26	wks	
1.	Nil	
2.	Older	age	
3.	Older	age	
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Karlsson	
et	al	1996	
[42]	
48	 3	 Patellofemoral	
joint	evaluation	
scale		
Univariate	
(p≤0.001)	
11	yrs	 No	variables	found	 -	 None	
specified	
Quadriceps	isometric	
activation.	Straight	leg	
rises	with	angle	weights	
and	inner	range	quad	with	
ankle	weights	(30-0°)	
Retrospective	
case-control	
study	
Kastelein	
et	al	2015	
[37]	
48	 21	 GROC	-	7	point		
	
Univariate	
(p<0.20)	then	
multivariate	
(p<0.10)		
52	wks	
	
Low/middle	education	level		
Poor	health	
Bilateral	symptoms	
Self-report	of	a	swollen	knee	
-	 None	
specified	
None	 Prospective	
cohort	study	
Kettunen	
et	al	2012	
[43]	
56	 6	 Kujala	Knee	
Pain	score	
Univariate	(p	
value	not	
specified)	
5	yrs	 No	variables	found	 -	 None	
specified	
Arthroscopic	surgery	–	
versus	-	home	exercise	
program	(8weeks)	
	
Randomized	
Controlled	
Trial	
Natri	et	
al	1998	
[40]	
49	 11	 1.	Pain	severity	
(VAS)	
2.	Lysholm	scale	
3.	Tegner	Scale	
Univariate	
(p<0.05)	then	
multivariate	
(p<0.05)	
7	yrs	 Greater	side	to	side	isometric	
quadriceps	muscle	strength	
difference	
-	 None	
specified	
Rest,	quadriceps	strength	,	
quadriceps	stretch,	Non-
steroidal	anti-
inflammatory	medication		
&	intra-articular	injections	
(n=33,	5x	-	1x/week)	of	
physiologic	saline	(n=17)	
or	glucosamine	(n=16)	
7	year	
Prospective	
cohort	study		
Nimon	et	
al	1998	
[8]	
63	 6	 1.	Pain	resent	
2.	Pain	severity		
3.	Analgesic	use	
4.	Pain	
frequency	
5.	Sport	
restriction	
6.	Pain	
associated	
activities	
5.	Other	
symptoms		
Univariate	(p	
not	specified)		
16	yrs	 No	variables	found	 -	 None	
specified	
Physiotherapy	and	laster	
immobilization	
Prospective	
cohort	study	
Pattyn	et	
al	2012	
[38]	
40	 21	 1.	Kujala	Knee	
pain	Scale	
2.	GROC	–	5-
point	Likert	
scale	
	
Univariate	
(p<0.05)	
7	wks	 Higher	frequency	of	pain	at	
baseline	
Smaller	quadriceps	muscle	size	
Greater	average	eccentric	peak	
torque	at	60°/sec	
R2	=	0.46	 None	
specified	
Mobilization,	
neuromuscular	
coordination	exercises,	
stabilization	exercises,	
strengthening	exercises,	
stretching,	cardiovascular	
and	home	exercise	
program	of	neuromuscular	
coordination	exercises		
Prospective	
cohort	study	
Rathleff	
et	al	2015	
[44]	
39	 2	 1.	PPT	localised		
2.	PPT	distal	
3.	GROC	–	7-
point	Likert	
scale	
Univariate	
(p<0.05)	
12	and		
52	wks	
No	variables	found	 -	 None	
specified	
Patient	education	–	versus	
-	patient	education	and	
exercises	therapy	
Randomized	
controlled	
trial	
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Wittstein	
et	al	2009	
[41]	
30	 4	 PT	Responders:	
resolution	of	
symptoms	to	
the	point	that	
they	required	
no	further	
treatment	
PT	Non-
responders:	
continued	to	
have	PFP	severe	
enough	that	
they	sought	
further	
treatment	
	 8	wks	 Evidence	of	chondromalacia	
patella	on	MR	imaging	
Tibial	tubercle	deviation	
>14.6mm		
	
-	 None	
specified	
Strengthening,	stretching,	
footwear	modification	and	
Non-steroidal	anti-
inflammatory	medication	
Retrospective	
case-control	
(comparative)	
study	
Witvrouw	
et	al	2002	
[35]	
30	 39	
	
1.	Kujala	Knee	
Pain	Scale	
2.	Manual	test	
(Q-angle,	
muscle	length,	
patellar	glide)	
3.	Subjective	
assessments	
4.	Functional	
assessments	
	 5	wks	 Slower	reflex	response	time	
(VMO)	
Longer	duration	of	symptoms	
	
-	 None	
specified	
No	sports	participation,	no	
medication	prescribed,	no	
brace	or	tape,	stretching	
exercises,	strength	
exercises	(Seated	leg	
press,	double	or	single	
one-third	knee	bend,	
stationary	bike	(10-15min	
@	100W),	rowing	
machine,	step	up	and	
down	(at	pain	free	height),	
progressive	jumping	
(3x1min))	and	home	
exercise	program	to	
maintain	strength	
Prospective	
cohort	study	
12	wks	 Slower	reflex	response	time	
(VMO)	
Longer	duration	of	symptoms	
	
GROC = global rating of change, PPT= pressure pain threshold, VMO = Vastus medialis obliquus, VAS = visual analogue 
scale, *foot note: all variables are listed in appendix 2 
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3.4 Patient characteristics associated with a successful outcome after a specific 
treatment  
Six different specific treatments were investigated; foot orthoses, [30 32 33 45-47] 
lumbopelvic manipulation, [34 48] patellar taping, [31] femoral nerve mobilization, [49] leg 
press exercise and stretching [28] and exercise therapy (consisting of static and dynamic 
exercises for the quadriceps muscles, flexibility and balance exercises) [50] (table 3). 
Twenty-two patient characteristics were reported to be associated with a successful 
outcome after a specific treatment. Studies defined a successful outcome using a 
predetermined amount of improvement in pain scores, questionnaire and/or a rating on a 
global rating of changes scale to stratify respondents into successful or unsuccessful 
outcomes.  
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Table 3 Patient characteristics associated with a successful outcome from a specific treatment  
Author		 Intervention	 Comparator	 Outcome	
measure	
Sample	(n)	 Success	(n)	 Predictors	to	a	successful	outcome		 Significance	
level	(p)	
Positive	Likelihood	
Ratio	(95%	CI)	
Odds	Ratio	
(95%	CI)	
Barton	
2011a	[33]	
Foot	orthoses	 Nil	 5-pt	GROC	 60	 14	 Footwear	motion	control	properties	(weighted	mean)	>5.0	
Usual	pain	<22.0/100mm	(VAS)	
Ankle	Dorsiflexion	(knee	flexed)	<41.3°	
Reduced	pain	during	single	leg	squat	
0.05	 1.9	(1.1–3.1)		
2.5	(1.3–4.8)		
1.5	(0.71–3.3)		
3.0	(1.8–4.9)		
	
Barton	
2011b	[46]	
Foot	orthoses	 Nil	 5-pt	GROC	 26	 7	 Greater	rearfoot	eversion	relative	to	the	laboratory	floor		 0.05	 -	 -	
Crowell	&	
Wofford	
2012	[34]	
Lumbo-pelvic	
manipulation	
Nil	 11-pt	NPRS		
15-pt	GROC.	
44	 25	 Hip	IR	side	to	side	difference	>14°	
Ankle	dorsiflexion	(knee	flexed)	>16°	
Navicular	drop	>3mm	
No	self-reported	stiffness	sitting	>20	min		
Squatting	(most	painful	activity)	
0.05	 0.76	(0.05,	11.39)		
0.93	(0.78,	1.11)		
1.52	(0.54,	4.31)		
0.74	(0.46,	1.19)		
0.82	(0.49,	1.37)		
	
Huang	
2015	[49]	
Femoral	
nerve	
mobilization	
Nil	 10cm	VAS		
15-pt	GROC	
51	 28	 Significant	immediate	efficacy	
Bilateral	difference	in	hip	extension	angle	of	femoral	slump	
test	(>3°)	
0.05	 NA	
5.11	(1.28-20.30)	
	
Iverson	
2008	[48]	
Lumbo-pelvic	
manipulation	
Nil	 11-pt	NPRS	
15-pt	GROC.	
49	 22	 Hip	IR	side	to	side	difference	>14°	
Ankle	dorsiflexion	(knee	flexed)	>16°	
Navicular	drop	>3mm	
No	self-reported	stiffness	sitting	>20	min		
Squatting	(most	painful	activity)	
0.05	 4.9	(1.2,	20.8)		
2.0	(1.0,	3.9)		
1.91	(1.0,	3.6)		
2.0	(1.1,	3.4)		
2.3	(1.1,	4.7)		
	
Lan	2010	
[31]	
Patella	taping	 Nil	 100mm	VAS	 100	 66	 Smaller	Lateral	Patellofemoral	Angle	
Larger	Q	Angle	
Lower	BMI	
0.05	 -	 0.81	(0.70-0.95)	
1.14	(1.03-1.26)		
0.85	(0.75-0.98)		
Lankhorst	
2015	[50]	
Exercise	
therapy	(ET)		
Usual	care	
(UC)	
Kujala	scale	
11-pt	NPRS	
131	 At	3mth	
26(ET)	
21(UC)	
	
At	12	mth	
36(ET)	
30(UC)	
Nil	significant	a	 0.01	 -	 -	
Mills	2012	
[32]	
Foot	orthoses		 Wait-and-see	 6-pt	GROC	 40	 9(FO)	
1(W-S)	
Foot	orthoses:	Mid-foot	width	difference	>11.25mm	b	 0.05	 3.9	(1.07-14.1)	 	
Peng	2015	
[28]	
Leg	press	and	
stretching	
Nil	 10cm	VAS	 43	 24	 Difference	in	patella	tilt	angle	between	maximal	quadriceps	
contraction	and	quadriceps	relaxed	(measured	on	axial	CT)		
0.05	 -	 0.84	
Rathleff	
2015b	[47]	
Foot	orthoses	 Nil	 PFP	Severity	
Scale	
23	 12	 Immediate	decrease	in	the	medial-to-lateral	peak	force	
after	fitting	the	orthoses	during	drop	jump	task	
	
0.05	 -	 -	
Sutlive	
2004	[45]	
Foot	orthoses	
and	activity	
modification	
Nil	 15-pt	GROC	 50	 27	 Forefoot	alignment	≥2°	valgus	
Great	toe	extension	<78°	
Navicular	drop	test	≤3mm		
Uncertain	 4.0	(0.7–21.9)	
4.0	(0.7–21.9)	
2.3	(1.3–4.3)	
-	
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Vicenzino	
2010	[30]	
Foot	orthoses	 	 5-pt	Likert	
GROC	
42	 17	 Age	>25	years	
Mid-foot	width	difference	>10.96mm	
Height	<165cm	
Worst	pain	<53.25/	100mm	(VAS)	
0.05	 1.9	(1.1	to	3.1)	
3.0	(0.91	to	9.6)		
4.9	(1.2	to	20.9)		
1.5	(0.74	to	2.9)		
	
-	
GROC = global rating of change, PPT= pressure pain threshold, VMO = Vastus medialis obliquus, VAS = visual analogue 
scale, NPRS = Numerical Pain Rating Scale, a: Analysis of interaction used was a classification and regression tree 
approach, b: Analysis of interaction used was a liner regression modeling.  
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3.4.1 Foot orthoses  
Fourteen predictors were univariately associated with a successful outcome after foot 
orthoses treatment across six studies. [30 32 33 45-47] Four predictors were static 
measures of the foot; these were 2° or more of valgus forefoot alignment, 78° or less 
great toe extension, 3mm or less navicular drop [45] and two studies reporting a mid-foot 
width difference between weight bearing and non-weight bearing greater than 10.96mm. 
[30 32] Two studies investigated foot movements during functional tasks. One study used 
3-D kinematic analysis during gait to show those who had a successful outcome had a 
mean difference of 2.3° greater rearfoot eversion relative to the ground than those who 
reported an unsuccessful outcome. [46] The other study of a drop jump task reported 
those who had an immediate decrease in the medial-to-lateral peak foot loading went on 
to report improvements in pain and function after wearing foot orthoses for 12 weeks.[47] 
Two studies found baseline pain scores of usual pain less than 22.0 mm [33] and worst 
pain less than 53.25 mm [30] on a 100mm visual analogue scale predicted a successful 
outcome. One functional performance predictor was reduced pain during a single leg 
squat whilst wearing foot orthoses. [33] Ankle dorsiflexion range less than 41.3°, relative 
to the vertical, (measured as tibial inclination using a digital inclinometer placed anteriorly 
mid-tibia) during weight bearing ankle dorsiflexion with a bent knee also predicted a 
positive outcome. [33] The clinical utility of such a specific cut point has not been further 
studied or the finding replicated. Other demographic predictors reported were height less 
than 165 cm and age over 25 years. [30] In addition to the patient centric factors, those 
participants who wore footwear with reduced motion control properties, assessed using a 
footwear assessment tool, [51] were more likely to report a successful outcome when 
wearing an orthosis. [33]  
 
Three predictors (height, forefoot valgus alignment, great toe extension) had a reported 
LR+ range of 4.0 - 4.9 [30 45] but the 95% confidence intervals for these predictors were 
large raising greater uncertainty on the precision of these relationships. Three predictors 
of success had LR+ range between 2.5 to 3.9 and narrow confidence intervals; with two 
studies identifying midfoot width difference from weight bearing to non-weight bearing 
foot posture of >10.96mm [30] and >11.26mm, [32] reduced pain during single leg squat 
while wearing a foot orthosis and usual pain <22/100mm visual analogue scale.   
 
Two studies used multivariate analysis to evaluate a combination of predictors for clinical 
prediction rules for success after treatment by foot orthoses (table 4). Each study 
reported a different combination of four predictors, with a LR+ of 8.8 (95%CI 1.2-66.9) 
[30] and 11.1 (95%CI 2.7-46.9) [33] when three or more predictors were present, raising 
post-test probability of success to 85.4% and 78% respectively. These LR+ suggest a 
moderate to large and often conclusive shifts in probability of a successful outcome after 
foot orthoses treatment. No participants in either of the two studies presented with all four 
of the respective predictors (table 4). 
 
	17	
Clinical	predictors	of	outcome	systematic	review	manuscript	20160222	
Table 4 Derived Clinical Prediction Rules for a specific treatment  
Study	 Intervention	 Follow-
up	
(weeks)	
Predictors	within	the	rule		 n	of	
predictors	
Success/	
non-
success	
(n)	
Sensitivity	
(95%CI)	
Specificity	
(95%CI)	
Positive	
Likelihood	Ratio	
(95%	CI)	
Posttest	
Success	(%)	
Barton	2011a	
[33]	
Foot	
orthoses	
12	 Footwear	motion	control	properties	>5.0	
Usual	pain	<22.0/100mm	(VAS)	
Ankle	Dorsiflexion	(knee	flexed)	<41.3°	
Reduced	pain	during	single	leg	squat	
≥1	
≥2	
≥3	
All	4	
11/25	
11/16	
7/2	
0/0	
1.00	(0.74-1.00)	
1.00	(0.74-1.00)	
0.64	(0.35-0.85)	
0	
0.26	(0.14	-	0.42)	
0.54	(0.38	-	0.70)	
0.94	(0.81	-	0.98)	
0	
1.3	(1.1	-	1.6)	
2.2	(1.5	-	3.1)	
11.1	(2.7	-	46.9)	
0	
24	
41	
78	
0	
Crowell	&	
Wofford	2012	
[34]	
Lumbo-pelvic	
manipulation	
1	 Hip	IR	side	to	side	difference	>14°	
Ankle	dorsiflexion	(knee	flexed)	>16°	
Navicular	drop	>3mm	
No	self-reported	stiffness	sitting	>20	min	
Squatting	(most	painful	activity)	
≥2	
≥3	
≥4	
≥5	
-	
-	
-	
-	
0.72	(0.54–0.90)	
0.45	(0.23–0.67)	
0.16	(0.02–0.30)	
0.02	(0–0.07)	
0.11	(0–0.24)	
0.33	(0.14–0.52)	
0.84	(0.68–1.01)	
0.95	(0.85–1.0)	
0.8	(0.6–1.1)	
0.7	(0.4–1.2)	
1.0	(0.3–4.0)	
0.4	(0–10.5)	
-	
-	
-	
-	
Iverson	2008	
[48]	
Lumbo-pelvic	
manipulation	
1	 Hip	IR	side	to	side	difference	>14°	
Ankle	dorsiflexion	(knee	flexed)	>16°	
Navicular	drop	>3mm	
No	self-reported	stiffness	sitting	>20	min	
Squatting	(most	painful	activity)	
≥1	
≥2	
≥3	
≥4	
all	5	
0/11	
5/11	
8/1	
5/0	
2/0	
0.91	(0.71,	0.99)	
0.91	(0.71,	0.99)	
0.68	(0.45,	0.86)	
0.32	(0.15,	0.55)	
0.09	(0.02,	0.31)	
0.15	(0.04,	0.35)	
0.56	(0.35,	0.75)	
0.96	(0.81,	1.00)		
1.00	(0.84,	1.00)	
1.00	(0.84,	1.00)	
1.1	(0.87,	1.3)	
2.05	(1.3,	2.9)	
18.4	(3.6,	105.3)	
Infinite	(0.90,	
infinite)	
Infinite	(0.31,	
infinite)		
47	
63	
94	
100	
100	
Vicenzino	
2010	[30]	
Foot	
orthoses	
12	 Age	>25	years	
Mid-foot	width	difference	>10.96mm	
Height	<165cm	
Worst	pain	<53.25/	100mm	(VAS)	
≥1	
≥2	
≥3	
All	4	
17/16	
12/8	
6/1	
0/0	
1	(0.77	to	1.0)	
0.71	(0.44	to	
0.89)	
0.35	(0.15	to	
0.61)	
-	
0.36	(0.19	to	
0.57)	
0.68	(0.46	to	
0.84)	
0.96	(0.78	to	
0.99)	
-	
1.6	(1.2	to	2.1)	
2.2	(1.1	to	4.2)	
8.8	(1.2	to	66.9)	
-	
52.7	
59.5	
85.4	
-	
IR = internal rotation; (VAS) = visual analogue scale 
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3.4.2 Lumbopelvic manipulation  
Five predictors were identified using multivariate analysis and reported to be associated 
with a successful outcome after lumbopelvic manipulation. [48] A follow up study [34] on 
a different but similar sized PFP cohort failed to replicate the same five predictors 
reported by Iverson et al. [48] 
 
3.4.3 Patellar taping  
One study [31] reported three predictors of a successful outcome with patellar taping as 
described by McConnell. [52] After multivariate analysis, smaller lateral patellofemoral 
angle (an angle formed by the line between the femoral condyles and another line 
between the margins of the lateral facet of the patella) measured with radiographs in 30° 
of knee flexion, larger Q angle and a lower body mass index [31] were reported to be 
associated with a successful outcome. Larger Q angle was the only one of three reported 
predictors have an OR >1 (OR 1.14 95%CI 1.03-1.26).  
 
3.4.4 Femoral nerve mobilization 
One study [49] reported two predictors to be associated with a successful outcome after 
six sessions of femoral nerve mobilization. After multivariate analysis, significant 
immediate improvement after a femoral nerve mobilization and a bilateral difference of at 
least 3° in hip extension angle of the femoral slump test, which had a LR+ 5.1 (1.3-20.3), 
suggests a moderate shift in probability of successful outcome after femoral nerve 
mobilization.  
 
3.4.5 Exercise  
Two studies investigated predictors of successful outcome after exercise. One study 
compared exercise therapy to usual care and found no significant predictors of a 
successful outcome to exercise therapy. [50] One study evaluated a leg press training 
and lower limb muscle stretching exercise program. [28] Patellar tilt angle difference 
(PTA-d), which is the difference in patellar tilt angle in a quadriceps contracted (Qc) and a 
quadriceps relaxed (Qr) position measured on axial computed tomography, was 
associated with a successful outcome after a leg press strengthening and lower limb 
stretching program. [28] Those who had greater PTA-d (i.e greater realignment of the 
patella with quadriceps contraction) before beginning exercise treatment had greater 
reductions in pain after treatment. [28] The optimal cut-off value was −1.5° PTA-d 
(Qc−Qr) for the clinical discrimination of treatment success based on a minimum pain 
reduction of 1.5-cm on the VAS (sensitivity = 0.74, specificity = 0.71, LR+ 2.5). 
 
4.0 DISCUSSION: 
Our systematic review on PFP investigated baseline patient characteristics that were 
associated with a: (a) poor outcome (prognosis), or (b) successful outcome after a 
specific treatment (treatment effect modifiers) after more than one week. The review 
highlighted a large amount of non-significant association with a total of 180 patient 
characteristics being investigated by 24 studies. Twelve prognosis studies investigated 
104 characteristics and identified 16 prognostic factors associated with a poor outcome. 
Twelve studies reported that only 22 out of 100 potential treatment effect modifiers were 
associated with a successful outcome after a specific treatment. However, the review 
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identified significant methodological limitations in all studies appraised with the EAI and 
modified QUADCPR tools. Of the 12 studies that investigated prognostic factors, only one 
study, a randomized controlled trial, [34] controlled for treatment and showed it was not a 
confounder. Of the 12 studies that investigated potential treatment effect modifiers, 11 did 
not have a control condition or a comparator treatment. It is therefore unclear whether the 
22 baseline patient characteristics identified in these studies actually predict success 
following a specific treatment (treatment effect modifiers) or are just non-specific 
prognostic factors. As a result of these limitations, pooling and meta-analyses of the data 
were not warranted. Although definitive conclusions cannot be drawn until these 
methodological limitations are addressed, in order to make the best use of available 
evidence, our discussion will focus first on studies investigating prognostic factors for a 
poor outcome followed by studies that investigated potential treatment effect modifiers.  
 
Prognostic factors are important in the decision making process and managing patient 
expectations. [53] Persistent PFP symptoms could have a negative impact on the 
physiological and psychological well-being of an individual with PFP. [1 54 55] Of the 12 
studies that evaluated prognostic factors for a poor outcome, 16 characteristics were 
reported, but only five were investigated by more than three studies. Longer duration of 
knee pain, [27 35 36] older age, [39] greater usual pain severity and lower baseline 
anterior knee pain score [27] were factors of an unsuccessful outcome (table 5). Three of 
the five studies that evaluated duration of knee pain, one a large prospective study, 
reported a consistent finding of longer duration of pain (>4 months [35]) as an indicator of 
a poor outcome. Longer duration of symptoms as a poor prognostic indicator seems to be 
consistent across musculoskeletal conditions, [56] even in adolescents with knee pain.[1] 
It would appear prudent for clinicians to keep duration of symptoms in mind when 
consulting a patient with PFP. This prognostic factor should also be considered in 
guidelines and future research for the effective management/prevention of persistent 
PFP.  
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Table 5: Prognostic factors and potential treatment effect modifiers identified in this review. 
	 Modifiable	with	non-operative	treatment	 Potentially	modifiable	 Unable	to	modify	with	non-operative	
treatment	
Factors	associated	with	a	poor	outcome		
Prognosis	 Clinically	
measurable		
Swelling	of	knee	(self-reported)	[37]	
Lower	Kujala	score	[27]	
Higher	frequency	of	pain	[38]	
Bilateral	symptoms	[37]	
Lower	eccentric	knee	strength	[38]	
Larger	asymmetry	in	side-to-side	isometric	quads	strength	
[40]	
Low/middle	education	[37]	
Poor	health	[37]	
Longer	duration	[27	35	36])]	
Older	age	[39]	
Female	gender	[36]	
Patellar	hypermobility	[36]	
	
Not	standard	
clinical	
measurement		
Smaller	quads	cross	sectional	area	[38]	 Slower	VMO	reflex	
response	[35]	
	
Tibial	tubercle	lateral	deviation	>14.6mm[41]	
Chondromalacia	patella	[41]	
Factors	reported	to	be	associated	with	a	successful	outcome	to	a	specific	treatment	 	
Foot	orthoses	 Clinically	
measurable		
Midfoot	width	difference	>	11mm	[30	32]	
Ankle	dorsiflexion	(knee	flexed)	<41°	[33]	
Usual	pain	<	22/100mm	(VAS)	[33]	
Worst	pain	<53/100mm	(VAS)	[30]	
Reduced	pain	during	single	leg	squat	with	orthoses	fitted[33]	
Footwear	motion	control	properties	(weighted	mean)	<5[33]	
-	 Height	<	165cm	[30]	
Age	>	25	yrs	[30]	
	 Not	standard	
clinical	
measurement	
Greater	rearfoot	eversion	relative	to	floor	[46]	
Reduced	medial-lateral	peak	force	during	drop-jump	[47]	
	 	
Patellar	
Taping		
Clinically	
measurable		
Lower	Body	Mass	Index	[31]	
	
	 Larger	Q-angle	[31]		
	
Not	standard	
clinical	
measurement	
	 Smaller	lateral	
patellofemoral	angle	[31]	
	
	
Leg	press	&	
stretching	
lower	limb	
muscles	
Not	standard	
clinical	
measurement	
	 Difference	in	patellar	tilt	
angle	between	maximum	
quadriceps	contraction	and	
quadriceps	relaxed	[28]	
-	
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Twelve studies evaluated potential treatment effect modifiers associated with a 
successful outcome after a specific treatment with four conducting multivariate analyses 
to report clinical prediction rules for either foot orthoses, [30 33] or lumbopelvic 
manipulation. [34 48] A limitation of these single group studies identified in the 
QUADCPR appraisal was (a) the absence of an appropriate comparator intervention, [57] 
and (b) inadequate statistical power because limiting sample sizes were too small. Of the 
12 studies that investigated potential treatment effect modifiers, 11 did not have a control 
condition or a comparator treatment. Lack of a control condition or a comparator 
treatment means there is no way to know that the outcome was necessarily due to the 
specific treatment. It is therefore unclear whether the baseline patient characteristics 
identified in these studies actually predict success following a specific treatment 
(treatment effect modifiers) or are just non-specific prognostic factors. The risk of 
spurious findings when overfitting or underfitting data to the limiting sample size was 
highlighted in a replication study of lumbopelvic manipulation for PFP [34] which used the 
same methods as the original study [48] but achieved contrasting results. Replication 
studies play an important role in predictive performance in a second, independent 
sample, especially when there are concerns about overfitting/underfitting data in the 
original study because of a relatively small limiting sample size. These studies need 
careful consideration in design that allow for an analysis of the interaction between 
treatment group and status on the prediction rule. 
 
Foot orthoses were the most common treatment in studies that attempted to identify 
potential treatment effect modifiers (6 studies). One factor that was identified by two 
studies [30 32] and formed part of a multivariate clinical prediction rule, was midfoot width 
difference of greater than 11mm, reported by Mills et al. [32] This study was the only one 
of the 13 studies looking at treatment effect modifiers to use a control group (wait-and-
see approach). [32] Mills et al [32] provide preliminary evidence that midfoot width 
difference might be useful at identifying those who might benefit from a foot orthosis, 
beyond natural history of the condition in the short term. This provides the clinician some 
useful information/evidence beyond any prognostic value of this foot characteristic.  
 
Whilst single group studies cannot distinguish between treatment effect modifiers and 
non-specific prognostic factors, they can identify prognostic factors that could potentially 
be treatment effect modifiers. Rather appropriately the bulk of identified factors that might 
predict success with foot orthoses, were based at or around the foot. The two studies 
reporting clinical prediction rules for prescribing foot orthoses reported likelihood ratios 
that could signify a moderate to large and often conclusive shift in probability of a 
successful treatment. [26] The factors that are most likely to be clinically modifiable are 
ankle dorsiflexion (tibial inclination <41.3° from the vertical),[33] mid-foot width difference 
(>11mm) [30 32] and footwear motion control properties (weighted mean >5). [33] An 
interesting clinical examination finding that contributed to one of these clinical prediction 
rules was a positive treatment direction test, [58] which is essentially the immediate 
reduction in pain with a single leg squat on initial wearing of a foot orthosis. [33] 
Somewhat consistent with the report of a positive treatment direction test [33] is the 
finding of an immediate decrease in medial-to-lateral peak foot force with fitting a foot 
orthosis being associated with a successful outcome. [47] In another laboratory study, 
kinematic analysis found those with greater rearfoot eversion relative to the floor, would 
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also successfully respond to foot orthoses. [46] Taking the findings collectively, there 
appears to be a body of exploratory results from single group studies that suggests the 
ability of the reported clinically measureable and modifiable prognostic factors to be 
potential treatment effect modifiers to identify those who would be successful with foot 
orthoses (table 5). Further research is necessary to investigate clinically relevant and 
plausible prognostic factors from single group studies in appropriately designed clinical 
trials to test for their ability to be treatment effect modifiers. In particular, midfoot width 
difference should be further explored as a treatment effect modifier for foot orthoses 
compared to other treatments because it has been shown to predict success with foot 
orthoses when compared to no intervention. 
 
In clinical practice, a positive finding of reproduction of symptoms with a femoral slump 
test, that reduced with neck extension, would reasonably direct the clinician to consider 
using femoral nerve mobilisations in patients who have PFP. Only one study reported 
clinical features that predicted success after femoral nerve mobilization treatment. [49]. In 
addition to the limitations of the single-group design, the authors used a modified testing 
protocol for the femoral slump test that is not easy to replicate in a timely manner in 
clinical practice. It is questionable the degree of confidence with which a clinician could 
determine a 3° difference from side to side as the authors did not report the error of this 
test measurement, so it is difficult to know if 3° exceeds measurement error. 
Nevertheless, further investigation of this treatment approach is warranted.  
 
Patellar taping, strengthening and stretching exercises of the thigh and lower limb 
muscles are often recommended to treat PFP. [52] A study by Lan et al [31] reported that 
success following patellar taping was associated with lateral patellofemoral angle and Q 
angle. Peng et al [28] measured the difference in patellar tilt angle between relaxed and 
contracted states of the quadriceps, noting a greater difference i.e., greater realignment 
of the patella with a contracted quads with treatment success. Notably though, all these 
measures from single studies of patellar position were made with radiological imaging, 
which is not readily accessible in a typical clinical setting (table 5).  
 
A series of important methodological issues were identified in the reviewed studies. 
Prognostic studies should ideally be prospective in design, [12] but in order to review all 
available studies that reported prognostic factors, weaker-designed retrospective studies 
were also included in this in review. Studies investigating predictors of a successful 
outcome after a specific treatment usually analyzed too many potential predictors for the 
limiting sample size. This increases the risk of over-fitting (or under-fitting) the data which 
can lead to the identification of predictors that are implausible and likely to perform poorly 
in new samples of patients [29] The absence of comparator interventions in studies 
investigating outcomes after a specific treatment make it difficult to differentiate between 
treatment effect modifiers and non-specific prognostic factors. Future studies should 
determine a sufficient limiting sample size to order to guide recruitment of an appropriate 
sample size. [25] Lastly, studies need to apply appropriate blinding where possible for 
participants and treating clinicians, but it is critical to blind investigators assessing the 
outcome to minimize false positives, or negatives, and potential biases. 
 
5.0 CONCLUSION 
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This review of relationships between patient characteristics and treatment outcomes for 
PFP identified that methodological limitations such as the absence of a 
control/comparator group, or too many predictors for the limiting sample size, make it 
unclear whether the predictors reported actually modify treatment effects. Despite the 
limitations inherent in current research evidence we identified modifiable 
and measurable factors that have been studied so as inform hypotheses that may help in 
the clinical decision making process (table 5). Three prognostic studies of patient 
characteristics identified that persistence of PFP beyond 4 months should alert clinicians 
to increased risk of a poor outcome. Greater change in midfoot width from non-weight 
bearing to weight bearing was the only characteristic that had sufficient evidence for 
being a potential treatment effect modifier for a successful outcome after foot orthoses 
treatment. The LR+ suggested a small but sometimes important shift in probability of a 
successful outcome, and this characteristic did not predict short-term improvement in a 
control group who received no intervention. Adequately powered randomized trials that 
compare relevant treatments are needed so that treatment can be tailored to the 
individual patient. 
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